Recent Material Events - Cell Genesys, Inc (CEGE)

Filing Date	Description
2008-09-11	The press release contains forward-looking statements which involve certain risks and uncertainties that could cause actual results to differ materially from those expressed or implied by these statements. Please refer to the cautionary note in the p ...
2008-08-27	The press release contains forward-looking statements which involve certain risks and uncertainties that could cause actual results to differ materially from those expressed or implied by these statements. Please refer to the cautionary note in the p ...
2008-08-01	On August 1, 2008, Cell Genesys, Inc. issued a press release announcing the financial results for the second quarter ended June 30, 2008. A copy of the press release is attached hereto as Exhibit 99.1 and hereby incorporated by reference. ...
2008-05-12	In connection with the offering, the Company entered into a subscription agreement, dated May 9, 2008 (the “Subscription Agreements”), between the Company and the investors. The form of Subscription Agreement is attached hereto as Exhibit 1 ...
2008-01-15	On January 14, 2008, Cell Genesys, Inc. issued a press release announcing that the Independent Data Monitoring Committee (IDMC) for VITAL-1, the first of two ongoing Phase 3 clinical trials of GVAX immunotherapy for prostate cancer, has completed a p ...
2007-12-20	On December 19, 2007, Cell Genesys, Inc. entered into a Technology and Intellectual Property Agreement with GBP IP, LLC, a Delaware limited liability company, or GBP, and an affiliate of GBP Capital, the majority shareholder in the privately-held Len ...
2007-10-23	On October 17, 2007, the Board of Directors of the Company unanimously amended the current bylaws of the Company and adopted an Amended and Restated Bylaws (the “Amended and Restated Bylaws”). The amendment to Article V clarifies the ...
2007-03-01	On March 1, 2007, Cell Genesys, Inc. issued a press release announcing the financial results for the fourth quarter and year ended December 31, 2006. A copy of the press release is attached hereto as Exhibit 99.1 and hereby incorporated by reference.... ...
2007-02-06	On December 29, 2006 we gave notice to our stockholders that a Special Meeting of Stockholders would be held on February 6, 2007 in order to approve a proposed exchange of outstanding stock options for options to purchase a lesser number of shares at... ...
2007-02-05	On February 5, 2007, Cell Genesys, Inc. entered into a Committed Equity Financing Facility, or CEFF, with Kingsbridge Capital Limited. Pursuant to the CEFF, Kingsbridge committed to purchase, subject to certain conditions, shares of our common stock... ...